Clinical outcomes following prolonged refractory status epilepticus (PRSE)

Neurocritical Care

Volumn 18, Issue 3, 2013, Pages 374-385

  Kilbride, R D ^a   Reynolds, A S ^b   Szaflarski, J P ^c   Hirsch, L J ^d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NEUROLOGICAL INSTITUTE   (United States)

^c The University of Alabama at Birmingham   (United States)

^d YALE UNIVERSITY   (United States)

Author keywords

Neuro ICU; Outcomes; PRSE; Status epilepticus

Indexed keywords

ANTICONVULSIVE AGENT; PENTOBARBITAL;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; COHORT ANALYSIS; COMA; CONTROLLED STUDY; DISABILITY; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; NEUROIMAGING; NEUROSURGERY; PREDICTION; PRIORITY JOURNAL; PROLONGED REFRACTORY STATUS EPILEPTICUS; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANESTHETICS, GENERAL; COHORT STUDIES; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; STATUS EPILEPTICUS; TREATMENT FAILURE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84878019883     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-013-9823-4     Document Type: Article

References (12)

1. Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol. 2002;59(2):205-10.
2. DeLorenzo RJ, Hauser WA, Towne AR, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. 1996;46:1029-35.
3. Lowenstein DH, Alldredge BK. Status epilepticus. N Engl J Med. 1998;338:970-6.
4. Cooper A, Britton JW, Rabinstein AA. Functional and cognitive outcome in prolonged refractory status epilepticus. Arch Neurol. 2009;66(12):1505-9. doi: 10.1001/archneurol.2009.273.
5. Drislane FW, Lopez MR, Blum AS, Schomer DL. Survivors and nonsurvivors of very prolonged status epilepticus. Epilepsy Behav. 2011;22(2):342-5.
6. Bramstedt KA, Morris HH, Tanner A. Now we lay them down to sleep: ethical issues with the use of pharmacologic coma for adult status epilepticus. Epilepsy Behav. 2004;5(5):752-5.
7. van Swieten J, Koudstaal P, Visser M, Schouten H, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604-7.
8. Young GB, Kreeft JH, McLachlan RS, et al. EEG and clinical associations with mortality in comatose patients in a general intensive care unit. J Clin Neurophysiol. 1999;16:354-60.
9. Austin EJ, Wilkus RJ, Longstreth WT Jr. Etiology and prognosis of alpha coma. Neurology. 1988;38:773-7.
10. Aminoff MJ, Simon RP. Status epilepticus. Causes, clinical features and consequences in 98 patients. Am J Med. 1980;69(5):657-66.
11. Holtkamp M, Othman J, Buchheim K, Masuhr F, Schielke E, Meierkord H. A "malignant" variant of status epilepticus. Arch Neurol. 2005;62:1428-31.
12. Hocker S, Britton JW, Mandrekar J, Wijdicks EFM, Rabinstein AA. Predictors of outcome in refractory status epilepticus. JAMA Neurol. 2012;1-6. doi: 10.1001/archneurol.2013.578.